UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                             ----------------------


                                    FORM 8-A



                FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                     PURSUANT TO SECTION 12(b) OR (g) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                         AMERICAN BIO MEDICA CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)




               New York                             141702188
        -----------------------                   ------------
        (State of incorporation                   (IRS Employer
           or organization)                     Identification No.)

           102 Simons Road
         Ancramale, New York                          12503
- ----------------------------------------         -------------------
(Address of Principal Executive Offices)            (Zip Code)


        Securities to be registered pursuant to Section 12(b) of the Act:
      

        Title of each class                Name of each exchange on which
        to be so registered                each class is to be registered
        -------------------                ------------------------------
                                      None

        Securities to be registered pursuant to Section 12(g) of the Act:

                          Common Shares, $.01 par value

                                       1


     Item 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED

     The Registrant  hereby  incorporates by reference herein the description of
the  Registrant's  Common Stock,  $.01 par value per share,  appearing under the
caption,  "Description of Securities" in the Registrant's Registration Statement
on Form 10SB,  as filed with the  Securities  and  Exchange  Commission  as such
section was amended  until the time such  Registration  Statement  was  declared
effective. The Company's Certificate of Incorporation and amendments thereto are
filed as Exhibits 3.1, 3.2, 3.3, 3.4 and 3.6 and its Bylaws are filed as Exhibit
3.5, respectively, to the aforesaid Registration Statement on Form 10-SB.

     Item 2. EXHIBITS

     The following exhibits are filed as part of the Registration Statement.

2(a) Registration  Statement  on Form  10SB,  as filed with the  Securities  and
     Exchange Commission on July 23, 1996 and as subsequently  amended and filed
     on November 21, 1996 and December 26, 1996.

2(b) Amended Certification of Incorporation (1).

2(c) Terms of 8% Cumulative Convertible Preferred Stock, Series A (2).

2(d) Bylaws (3).

2(e) Copy of form of stock certificate for the Registrant's Common Stock (4).

                          -----------------------------

(1)  Incorporated  herein by reference to Exhibits 3.1, 3.2, 3.3, 3.4 and 3.6 of
     the Registrant's Registration Statement on Form 10SB.

(2)  Incoporated  herein  by  reference  to  Exhibits  4.3 of  the  Registrant's
     Registration Statement on Form 10SB.

(3)  Incorporated  herein  by  reference  to  Exhibit  3.5 of  the  Registrant's
     Registration Statement on Form 10SB.

(4)  Incorporated  herein  by  reference  to  Exhibit  4.1 of  the  Registrant's
     Registration Statement on Form 10SB.


                                       2


                                    SIGNATURE

     Pursuant to the  requirements of Section 12 of the Securities  Exchange Act
of 1934, the Registrant has duly caused this Registration Statement to be signed
on its behalf by the undersigned, thereunto duly authorized.


                               AMERICAN BIO MEDICA CORPORATION
                                      (Registrant)

                               By: s/Stan Cipkowski
                                   ----------------
                                   Stan Cipkowski,
                                   President and Principal
                                   Executive Officer and
                                   Principal Financial Officer



     Dated: March 12, 1997